Literature DB >> 849004

Neonatal hypocalcaemia after intrauterine exposure to anticonvulsant drugs.

B Friis, H Sardemann.   

Abstract

Two cases are reported of prolonged hypocalcaemia with tetany in infants born at term, whose mothers had been treated with phenytoin and phenobarbitone in high doses. Both infants presented with jitteriness and tetany in the first and second weeks of life, and in both the hypocalcaemia was resistant to therapy over a longer period. An effect on the fetal vitamin D metabolism by phenytoin and phenobarbitone, resulting in defective bone mineralization and neonatal hypocalcaemia is suggested.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 849004      PMCID: PMC1546284          DOI: 10.1136/adc.52.3.239

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  Calcium metabolism in pregnancy and in the newborn.

Authors:  P J Watney; B T Rudd
Journal:  J Obstet Gynaecol Br Commonw       Date:  1974-03

2.  Human perinatal vitamin D metabolism. I. 25-Hydroxyvitamin D in maternal and cord blood.

Authors:  L S Hillman; J G Haddad
Journal:  J Pediatr       Date:  1974-05       Impact factor: 4.406

3.  Neonatal hypocalcaemia. "Early type" in low birth weight newborns.

Authors:  A Rösli; A Fanconi
Journal:  Helv Paediatr Acta       Date:  1973-11

4.  Diphenylhydantoin: placental transport, fetal localization, neonatal metabolism, and possible teratogenic effects.

Authors:  B L Mirkin
Journal:  J Pediatr       Date:  1971-02       Impact factor: 4.406

5.  Effects of long-term anticonvulsant therapy on calcium and vitamin D metabolism.

Authors:  T C Stamp
Journal:  Proc R Soc Med       Date:  1974-01

6.  "Anticonvulsant action" of vitamin D in epileptic patients? A controlled pilot study.

Authors:  C Christiansen; P Rodbro; O Sjö
Journal:  Br Med J       Date:  1974-05-04
  6 in total
  1 in total

Review 1.  Drug-induced electrolyte abnormalities.

Authors:  E P Brass; W L Thompson
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.